Loading…
Celldex Therapeutics, Inc. is projected to rise to $54.45 by 2027, a +39% move from its current price of $39.11. CLDX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $38.24 | $39.12 | $40.01 | +0.02% |
| Jul 14 | $37.89 | $39.13 | $40.40 | +0.04% |
| Jul 15 | $37.63 | $39.13 | $40.69 | +0.06% |
| Jul 16 | $37.41 | $39.14 | $40.95 | +0.08% |
| Jul 17 | $37.22 | $39.15 | $41.18 | +0.10% |
| Jul 18 | $37.05 | $39.16 | $41.38 | +0.12% |
| Jul 19 | $36.89 | $39.16 | $41.57 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.89 | $39.16 | $41.57 | +0.13% |
| Week 2 | $36.04 | $39.22 | $42.67 | +0.27% |
| Week 3 | $35.41 | $39.27 | $43.55 | +0.40% |
| Week 4 | $34.89 | $39.32 | $44.31 | +0.54% |
| Week 5 | $34.45 | $39.37 | $45.00 | +0.68% |
| Week 6 | $34.06 | $39.43 | $45.64 | +0.81% |
| Week 7 | $33.71 | $39.48 | $46.24 | +0.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Celldex Therapeutics, Inc. is a healthcare company focused on developing therapeutic antibodies for inflammatory, allergic, autoimmune, and other diseases. Its drug candidates include Barzolvolimab (CDX-0159), a monoclonal antibody that binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases that targets two complementary pathways and neutralizes thymic stromal lymphopoietin while depleting mast cells through stem cell factor starvation.
Celldex Therapeutics is headquartered in Hampton, New Jersey.
Celldex Therapeutics, Inc. is a healthcare stock with a current price of $37.44 and a market capitalization of $2.94B. The company holds a rank of 1695.
A major floor 37.4% below — a decisive break under it would weaken the trend.
The nearest floor, 27.0% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 20.8% above — clearing it would confirm fresh momentum.
Key CLDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.99 | Buy | $38.77 | Buy |
| MA 10 | $38.00 | Buy | $37.75 | Buy |
| MA 20 | $35.26 | Buy | $35.96 | Buy |
| MA 50 | $32.89 | Buy | $33.67 | Buy |
| MA 100 | $31.73 | Buy | $31.84 | Buy |
| MA 200 | $28.87 | Buy | $29.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.51 | Sell |
| Stoch RSI (14) | 65.94 | Neutral |
| CCI (20) | 93.73 | Neutral |
| Williams %R (14) | -11.80 | Info |
| MACD (12,26,9) | 0.42 | Buy |
| ROC (12) | 18.59 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 88.20 | Sell |
| TRIX (15) | 0.74 | Buy |
| Awesome (5,34) | 5.84 | Buy |
| Ultimate (7,14,28) | 70.50 | Sell |
| Momentum (10) | 5.02 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 39.64 | Sell |
| ADX (14) | 31.59 | Buy |
| ATR (14) | 0.74 | Info |
The stock shows a bullish technical picture, with RSI14 at 70. The 50-day simple moving average is $32.17 and the 200-day simple moving average is $28.33. Support is at $28.56 and resistance at $37.44. The 30-day price range spans from $32.07 to $43.70, indicating a recent trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.58 | $39.11 | $50.43 | 0% | Neutral | |
| $44.04 | $54.45 | $70.76 | +39% | Bullish | |
| $48.29 | $61.07 | $81.90 | +56% | Bullish | |
| $52.95 | $68.22 | $93.78 | +74% | Bullish | |
| $57.85 | $75.77 | $106.34 | +94% | Bullish | |
| $61.36 | $81.57 | $116.59 | +109% | Bullish | |
| $69.59 | $93.81 | $136.30 | +140% | Bullish | |
| $79.73 | $108.88 | $160.57 | +178% | Bullish | |
| $92.51 | $127.88 | $191.20 | +227% | Bullish | |
| $103.46 | $144.71 | $219.13 | +270% | Bullish | |
| $149.42 | $220.27 | $351.98 | +463% | Bullish | |
| $271.22 | $436.87 | $755.59 | +10.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $22.58 | $39.11 | $46.59 | +0.00% |
| August 2026 | $33.17 | $38.97 | $46.87 | -0.37% |
| September 2026 | $33.68 | $39.80 | $48.32 | +2.15% |
| October 2026 | $34.32 | $40.75 | $49.87 | +2.38% |
| November 2026 | $33.90 | $40.42 | $49.79 | -0.81% |
| December 2026 | $34.00 | $40.70 | $50.43 | +0.69% |
Click any year to see its month-by-month CLDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CLDX to range from $22.58 to $50.43 through 2026. The $39.11 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CLDX price prediction for 2027 points to an average of $54.45 (low $44.04, high $70.76) — a potential gain of +39% on today's $39.11. Buyers look set to stay in control over this stretch.
In 2028, CLDX is projected to trade between $48.29 and $81.90, averaging $61.07 — a potential gain of +56% from today's $39.11. That is up +12% on the projected 2027 average. Momentum favours further upside here.
Celldex Therapeutics, Inc.'s 2029 outlook centres on $68.22, within a $52.95 to $93.78 range. That is up +12% on the projected 2028 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CLDX could reach as high as $106.34, with a base case around $75.77 and support toward $57.85 — roughly +94% from $39.11. Momentum favours further upside here.
Expect CLDX to range from $61.36 to $116.59 through 2031. The $81.57 average target implies a +109% move from current prices. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CLDX price prediction for 2032 points to an average of $93.81 (low $69.59, high $136.30) — a potential gain of +140% on today's $39.11. Momentum favours further upside here.
In 2033, CLDX is projected to trade between $79.73 and $160.57, averaging $108.88 — a potential gain of +178% from today's $39.11. That is up +16% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Celldex Therapeutics, Inc.'s 2034 outlook centres on $127.88, within a $92.51 to $191.20 range. That is up +17% on the projected 2033 average. That marks a +227% change versus current levels. Momentum favours further upside here.
By 2035, CLDX could reach as high as $219.13, with a base case around $144.71 and support toward $103.46 — roughly +270% from $39.11. Buyers look set to stay in control over this stretch.
Expect CLDX to range from $149.42 to $351.98 through 2040. The $220.27 average target implies a +463% move from current prices. That is up +52% on the projected 2035 average. Momentum favours further upside here.
The CLDX price prediction for 2050 points to an average of $436.87 (low $271.22, high $755.59) — a potential gain of +10.2x on today's $39.11. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLDX today (≈ 25.568908 CLDX) could be worth
$11,170.39
+$10,170.39 (+1017%) by 2050 · US Dollar
Based on the average projected CLDX price of $436.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLDXwould be worth at today's price.
$1,000 invested in CLDX on Jul 10, 2025 (≈ 44.09171 CLDX) would be worth
$1,724.43
+$724.43 (+72.4%) today · 1.72× · US Dollar
Based on a CLDX entry price of $22.68 vs. today's $39.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.37 | $1,019.29 | +1.9% |
| 1 month ago | $29.35 | $1,332.54 | +33.3% |
| 3 months ago | $32.24 | $1,213.09 | +21.3% |
| 6 months ago | $25.67 | $1,523.57 | +52.4% |
| 1 year ago | $22.68 | $1,724.43 | +72.4% |
| All time (5.0y) ago | $44.6 | $876.91 | -12.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLDX forecast.
Our base-case forecast reaches $78.00 around 2031.
Implied market cap at $78.00: $6.12B
The multi-year forecast shows a path of rising averages and returns. In 2026 the average price is projected at $37.44 with a neutral sentiment. By 2027 the average price is $54.60 with a 45.8% ROI and bullish sentiment, rising further to 2028 at $60.96 (62.8% ROI) and 2029 at $70.01 (87% ROI).
The 2030 projection is an average of $79.17 with a 111.5% ROI and bullish sentiment. Later years continue the uptrend, with 2031 at $85.09 (127.3%), 2032 at $101.28 (170.5%), and 2033 at $119.31 (218.7%). The forecast extends to 2034 at $139.50 (272.6%), 2035 at $161.91 (332.4%), 2040 at $252.21 (573.6%), and 2050 at $519.09 (1286.5%), all with bullish sentiment.
These numbers imply meaningful upside over time but are estimates, not guarantees, and come with uncertainty and risk.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $79.17, with a minimum of $60.09, a maximum of $111.95, and a reported ROI of 111.5% with bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising average prices and positive ROI (e.g., 2027 avg $54.60, ROI 45.8%; 2030 avg $79.17, ROI 111.5%; 2040 ROI 573.6%; 2050 ROI 1286.5%). These are estimates and not guarantees, and investment outcomes depend on many factors.
Yes. The 2030 maximum is $111.95, which exceeds $100.
Current price is $37.44 and market capitalization is $2.94B.
The 30-day price range is from $32.07 to $43.70.
Celldex Therapeutics, Inc. Community Discussion
0Share your Celldex Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.